Company · Healthcare
Everlife Holdings + Translumina Therapeutics.
PrivateTracked across 1 covered firm · 1 equity · 0 creditVintage Sep 2026Healthcare sector dossier →
Equity holders · 1
| Firm | Entered | Entry | Status | 12-mo | Read |
|---|---|---|---|---|---|
| Everstone Group | 2019 | Control stakes (70% Everlife, 60% Translumina) | Private | · | Merger of the two platforms announced Jun 2024 ahead of a targeted Oct 2025 IPO at a combined ₹6,000 Cr (~$720M) valuation; no DRHP filed as of Sep 2026 — the listing has slipped. |
Aggregated from Gravitywell's tracked position books: covered firms only, not the full cap table. Entries, stages and reads are per-holder reconstructions from public disclosures (E). Point-in-time as of Sep 2026.
Stay ahead